1994-2019.
All Rights Reserved. Online Journal of Veterinary
Research. You may not store these pages in any form except for your
own personal use. All other usage or distribution is illegal under
international copyright treaties. Permission to use any
of these pages in any other way besides the before mentioned must be gained in
writing from the publisher. This article is exclusively copyrighted
in its entirety to OJVR publications. This article may be copied once but may
not be, reproduced or re-transmitted without the express permission of the
editors.
OJVRTM
Online Journal of Veterinary Research©
Volume 22 (7):629-637, 2018.
Effect of Emblica officinalis
(Imipenem) and standard antibiotics on growth of resistant bacteria.
Ban
N. Nadhom, Waffa A. Ahmed, Narjes A. Abdulrazaq.
College of Veterinary Medicine, University of Baghdad,
Iraq.
ABSTRACT
Ban N. Nadhom, Waffa A. Ahmed, Narjes A. Abdulrazaq., Effect of Emblica
officinalis and standard antibiotics on growth of resistant bacteria., Onl J Vet Res., 22 (7):629-637,
2018. Emblica officinalis (Alma) phenolic extract was
subjected to phytochemical analysis by chromatography detecting ellagic, gallic,
chebulinic, chebulagic
acids, kaempferol, quericitin
and emblicanins. Then, effect of the extract and standard
antibiotics on growth of resistant Staphylococcus aureus,
Proteus spp., Escherichia coli and Bacillus spp. by
disk diffusion was performed. For Emblica
officinalis, 10 to 100mg/ml inhibition zones for S. aureus ranged 16±0.57 to
33.3±0.3mm, Bacillus spp. 11.3±0.6 to 28±0.06mm,
Escherichia coli 10.6±1.2 to 22.6±1.2mm
and Proteus spp. 8.2±0.1 to 20.3±0.57mm, respectively. We found E. coli
resistant to ampicillin or trimethoprim but susceptible to imipenem, Proteus
vulgaris resistant to clindamycin, erythromycin, vancomycin, cefotaxime
and trimethoprim, Staphylococcus aureus
resistant to cefotaxime, streptomycin, trimethoprim but susceptible to clindamycin
and vancomycin and Bacillus Spp. resistant
to streptomycin, trimethoprim and ampicillin but susceptible to imipenem, clindamycin
and erythromycin.
Key words:
Emblica officinalis, phytochemical, antibacterial action, E. coli, P.vulgaris, S. aureus,
B. spp.